Scientist Home Future Health Ltd
Data quality: 83%
SHFH
OTC
Manufacturing
Chemicals
Quick Summary
Key Takeaways
Negative free cash flow of -323,052.0
Capital intensive — 36.64% of revenue goes to capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-145.49%
Below sector avg (-51.02%)
ROIC-56.23%
Net Margin-113.56%
Op. Margin-113.56%
Safety
Debt / Equity
N/A
Current Ratio2.64
Interest CoverageN/A
Valuation
P/E Ratio
N/A
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (44 peers)
Peer Comparison
vs Manufacturing sector median (44 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | — | -2.0 |
| P/B | — | 5.1 |
| ROE % | -145.5 | -51.0 |
| Net Margin % | -113.6 | -150.2 |
| Rev Growth 5Y % | — | 9.3 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 204,055.0 | Net Income (TTM) | -231,725.0 |
| ROE | -145.49% | ROA | -55.32% |
| Gross Margin | 40.13% | Operating Margin | -113.56% |
| Net Margin | -113.56% | Free Cash Flow (TTM) | -323,052.0 |
| ROIC | -56.23% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2.64 |
| Interest Coverage | N/A | Asset Turnover | 0.49 |
| Working Capital | 202,344 | Tangible Book Value | 267,004 |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | N/A | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | N/A | ||
| Market Cap | N/A | Enterprise Value | N/A |
| Per Share | |||
| EPS (Diluted TTM) | -0.01 | Revenue / Share | N/A |
| FCF / Share | N/A | OCF / Share | N/A |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 36.64% | FCF Conversion | 139.41% |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 |
|---|---|
| Revenue | 204,055.0 |
| Net Income | -231,725.0 |
| EPS (Diluted) | -0.01 |
| Gross Profit | 81,887.0 |
| Operating Income | -231,725.0 |
| EBITDA | — |
| R&D Expenses | — |
| SG&A Expenses | 313,612.0 |
| D&A | — |
| Interest Expense | — |
| Income Tax | 0.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 |
|---|---|
| Total Assets | 644,365.0 |
| Total Liabilities | 530,974.0 |
| Shareholders' Equity | 113,391.0 |
| Total Debt | — |
| Cash & Equivalents | — |
| Current Assets | 192,246.0 |
| Current Liabilities | 214,458.0 |
{"event":"ticker_viewed","properties":{"ticker":"SHFH","listing_kind":"stock","pathname":"/stocks/shfh","exchange":"OTC","country":"US"}}